Venrock Healthcare Capital Partners III, L.P. 13D/13G Filings for Jade Biosciences, Inc. (JBIO)

Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Jade Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-05
4:26 pm
Purchase
2025-04-2813GJade Biosciences, Inc.
JBIO
Venrock Healthcare Capital Partners III, L.P.3,220,369
9.900%
3,220,369increase
(New Position)
Filing